Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4525949
Max Phase: Preclinical
Molecular Formula: C28H38O8
Molecular Weight: 502.60
Molecule Type: Unknown
Associated Items:
ID: ALA4525949
Max Phase: Preclinical
Molecular Formula: C28H38O8
Molecular Weight: 502.60
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CC(=C)CCC1(C)C(C)CC(=O)C23C(=C[C@H](OC(=O)C(C)C)CC12)[C@@H](OC(C)=O)O[C@H]3OC(C)=O
Standard InChI: InChI=1S/C28H38O8/c1-9-16(4)10-11-27(8)17(5)12-23(31)28-21(13-20(14-22(27)28)35-24(32)15(2)3)25(33-18(6)29)36-26(28)34-19(7)30/h9,13,15,17,20,22,25-26H,1,4,10-12,14H2,2-3,5-8H3/t17?,20-,22?,25-,26+,27?,28?/m0/s1
Standard InChI Key: IYFGATPPEMZGPO-KWCFWXNCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 502.60 | Molecular Weight (Monoisotopic): 502.2567 | AlogP: 4.43 | #Rotatable Bonds: 8 |
Polar Surface Area: 105.20 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.68 | CX LogD: 4.68 |
Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.21 | Np Likeness Score: 2.91 |
1. Cai S, Risinger AL, Petersen CL, Grkovic T, O'Keefe BR, Mooberry SL, Cichewicz RH.. (2019) Anacolosins A-F and Corymbulosins X and Y, Clerodane Diterpenes from Anacolosa clarkii Exhibiting Cytotoxicity toward Pediatric Cancer Cell Lines., 82 (4): [PMID:30830773] [10.1021/acs.jnatprod.8b01015] |
Source(1):